Lombard touts 1st commercial use of IntelliFlex LP with Aorfix stent graft

Lombard Medical Technologies (NSDQ:EVAR) today touted the 1st commercial use of its IntelliFlex low profile delivery system designed to implant the Aorfix endovascular stent graft in a procedure to treat an abdominal aortic aneurysm. The procedure was performed by Dr. Nilo Mosquera at Spain’s Complexo Hospitalario Universitario de Ourense on the 28th of June, the Irvine, Calif.-based company said. “My surgical team and I were very pleased with the performance of IntelliFlex LP. The device’s lower catheter profile was able to successfully navigate this particular patient’s calcified access vessels, something that in our experience might have not been possible with the previous generation’s delivery profile.  The enhanced control of the new Y-mechanism is a significant improvement in stent delivery technology and provides greater control and precision when deploying the proximal end of the devices, allowing for a very precise graft placement.  The integrated exchange sheath is also beneficial in reducing potential vessel trauma and facilitates the less invasive percutaneous approach,” Dr. Mosquera said in an SEC filing. The Intelliflex system, in addition to allowing for the delivery of the Aorfix endovascular stent, includes an integrated exchange sheath designed for the delivery of ancillary devices during the procedure, the company said. The design removes the need for catheter exchanges, which Lombard said saves procedure time, blood loss and poss...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Stent Grafts Surgical Lombard Medical Source Type: news